Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1928 1
1931 1
1932 1
1951 1
1952 1
1972 2
1975 9
1976 15
1977 13
1978 8
1979 17
1980 15
1981 20
1982 19
1983 22
1984 28
1985 30
1986 32
1987 20
1988 41
1989 46
1990 42
1991 54
1992 51
1993 74
1994 93
1995 113
1996 101
1997 128
1998 131
1999 124
2000 163
2001 152
2002 156
2003 160
2004 188
2005 189
2006 195
2007 210
2008 223
2009 241
2010 293
2011 324
2012 365
2013 413
2014 418
2015 429
2016 489
2017 519
2018 634
2019 813
2020 1118
2021 1330
2022 1393
2023 694

Text availability

Article attribute

Article type

Publication date

Search Results

10,984 results

Results by year

Filters applied: . Clear all
Page 1
Cannabidiol (CBD) and its analogs: a review of their effects on inflammation.
Burstein S. Burstein S. Bioorg Med Chem. 2015 Apr 1;23(7):1377-85. doi: 10.1016/j.bmc.2015.01.059. Epub 2015 Feb 7. Bioorg Med Chem. 2015. PMID: 25703248 Review.
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must be seen as unfortunate since a number of actions of CBD with potential therapeutic benefit were downplayed for many years. ...Topics …
This was no doubt due to the belief that activity meant psychoactivity that was shown by THC and not by CBD. In retrospect this must …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Bonaccorso S, et al. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. Neurotoxicology. 2019. PMID: 31412258 Review.
However, CBD may present with a different activity compared with the psychotomimetic THC. Most typically, CBD is reported to be used in some medical conditions, including chronic pain. ...
However, CBD may present with a different activity compared with the psychotomimetic THC. Most typically, CBD is reported to b …
Cannabidiol (CBD) Use by Older Adults for Acute and Chronic Pain.
Porter B, Marie BS, Milavetz G, Herr K. Porter B, et al. J Gerontol Nurs. 2021 Jul;47(7):6-15. doi: 10.3928/00989134-20210610-02. Epub 2021 Jul 1. J Gerontol Nurs. 2021. PMID: 34191653 Free PMC article. Review.
Legalization of cannabidiol (CBD) products has ignited interest in clinical practice and research. One desired indication includes possible pain-relieving effects of CBD. The purposes of the current article are to (1) clarify terminology relevant to cannabinoids; (2 …
Legalization of cannabidiol (CBD) products has ignited interest in clinical practice and research. One desired indication includes po …
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age.
Crippa JA, Guimarães FS, Campos AC, Zuardi AW. Crippa JA, et al. Front Immunol. 2018 Sep 21;9:2009. doi: 10.3389/fimmu.2018.02009. eCollection 2018. Front Immunol. 2018. PMID: 30298064 Free PMC article. Review.
Results: CBD was shown to have anxiolytic, antipsychotic and neuroprotective properties. ...Discussion: CBD is an useful and promising molecule that may help patients with a number of clinical conditions. ...
Results: CBD was shown to have anxiolytic, antipsychotic and neuroprotective properties. ...Discussion: CBD is an useful and p …
Cannabidiol (CBD) in Cancer Management.
O'Brien K. O'Brien K. Cancers (Basel). 2022 Feb 10;14(4):885. doi: 10.3390/cancers14040885. Cancers (Basel). 2022. PMID: 35205633 Free PMC article. Review.
It has over 540 metabolites thought to be responsible for its therapeutic effects. Two of the key phytocannabinoids are cannabidiol (CBD) and tetrahydrocannabinol (THC). Unlike THC, CBD does not have potentially intoxicating effects. Preclinical and clinical researc …
It has over 540 metabolites thought to be responsible for its therapeutic effects. Two of the key phytocannabinoids are cannabidiol (CBD …
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiety-provoking events like public spea …
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures …
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
Li H, Liu Y, Tian D, Tian L, Ju X, Qi L, Wang Y, Liang C. Li H, et al. Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22. Eur J Med Chem. 2020. PMID: 32109623 Review.
Herein, 11 general types of natural cannabinoids from Cannabis sativa as well as 50 (-)-CBD analogues with therapeutic potential were described. The underlying molecular mechanisms of CBD as a therapeutic candidate for epilepsy and neurodegenerative diseases were co …
Herein, 11 general types of natural cannabinoids from Cannabis sativa as well as 50 (-)-CBD analogues with therapeutic potential were …
Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
Spinella TC, Stewart SH, Naugler J, Yakovenko I, Barrett SP. Spinella TC, et al. Psychopharmacology (Berl). 2021 Jul;238(7):1965-1977. doi: 10.1007/s00213-021-05823-w. Epub 2021 Apr 4. Psychopharmacology (Berl). 2021. PMID: 33813611 Free PMC article. Clinical Trial.
OBJECTIVES: We evaluated whether CBD expectancy alone could influence stress, anxiety, and mood, and the extent to which beliefs regarding CBD effects predicted these responses. ...However, participants who endorsed strong a priori beliefs that CBD has anxiol …
OBJECTIVES: We evaluated whether CBD expectancy alone could influence stress, anxiety, and mood, and the extent to which beliefs rega …
CBD for the treatment of pain: What is the evidence?
Svensson CK. Svensson CK. J Am Pharm Assoc (2003). 2020 Nov-Dec;60(6):e80-e83. doi: 10.1016/j.japh.2020.06.009. Epub 2020 Jul 4. J Am Pharm Assoc (2003). 2020. PMID: 32636158
Cannabidiol (CBD) has become widely available owing to recent changes in federal and state regulations. ...Thus, there is a physiological basis to investigate CBD for the treatment of pain. Although CBD has been found to reduce pain in several animal models o …
Cannabidiol (CBD) has become widely available owing to recent changes in federal and state regulations. ...Thus, there is a physiolog …
Cannabidiol (CBD) and cognition in epilepsy.
Gaston TE, Martin RC, Szaflarski JP. Gaston TE, et al. Epilepsy Behav. 2021 Sep 23;124:108316. doi: 10.1016/j.yebeh.2021.108316. Online ahead of print. Epilepsy Behav. 2021. PMID: 34563808 Review.
This targeted review discusses the currently available data on CBD's effects on cognition in epilepsy. First, we review the proposed mechanisms by which CBD could exert effects on cognition. Then, we present the pre-clinical/animal data investigating cognitive effec …
This targeted review discusses the currently available data on CBD's effects on cognition in epilepsy. First, we review the proposed …
10,984 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "cbd"